日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

RETRACTION: miR-107 Regulates Growth and Metastasis of Gastric Cancer Cells via Activation of the PI3K-AKT Signaling Pathway by Down-Regulating FAT4

撤稿:miR-107通过下调FAT4激活PI3K-AKT信号通路调控胃癌细胞的生长和转移

Shisiwei Jianzhong decoction inhibits the adipogenic differentiation of bone marrow mesenchymal stem cells by downregulating nuclear factor of activated T cells, cytoplasmic 4 in non-severe aplastic anemia

石菖蒲健中汤通过下调活化T细胞核因子胞质4(NFAT4)抑制非重型再生障碍性贫血中骨髓间充质干细胞的脂肪生成分化

Jun, Wang; Bo, Wang; Yun, Zhang; Shengyun, Lin; Liqiang, W U

LATS2 and FAT4 as key candidate genes of hippo pathway associated with the risk and progression of breast cancer: an in-silico approach

LATS2 和 FAT4 作为 Hippo 通路的关键候选基因与乳腺癌的风险和进展相关:一种计算机模拟方法

Sadaf; Zafar, Mubashir; Massey, Sheersh; Aloliqi, Abdulaziz A; Anwar, Sadaf; Ali, Abrar; Hussain, Malik Asif; Bhardwaj, Tulika; Dev, Kapil

SHP2 mediates the ROS/JNK/NFAT4 signaling pathway in gastric cancer cells prompting lncRNA SNHG18 to drive gastric cancer growth and metastasis via CAR-T cells

SHP2介导胃癌细胞中的ROS/JNK/NFAT4信号通路,进而促使lncRNA SNHG18通过CAR-T细胞驱动胃癌的生长和转移。

An, Lin; Huo, Yue; Xiao, Na; Su, Shenyong; Wang, Kunjie

FAT4 Mutation is Related to Tumor Mutation Burden and Favorable Prognosis in Gastric Cancer

FAT4 突变与胃癌的肿瘤突变负荷和良好预后相关

Li, Qingqing; Chu, Yuxin; Yao, Yi; Song, Qibin

FAT4 overexpression promotes antitumor immunity by regulating the β-catenin/STT3/PD-L1 axis in cervical cancer

FAT4 过表达通过调节宫颈癌中的 β-catenin/STT3/PD-L1 轴促进抗肿瘤免疫

Dongying Wang ,Shuying Wu ,Jiaxing He ,Luguo Sun ,Hongming Zhu ,Yuxuan Zhang ,Shanshan Liu ,Xuefeng Duan ,Yanhong Wang ,Tianmin Xu

FAT4 loss initiates hepatocarcinogenesis through the switching of canonical to noncanonical WNT signaling pathways

FAT4 缺失通过经典 WNT 信号通路向非经典 WNT 信号通路的转换启动肝癌发生。

Huang, Fung-Yu; Wong, Danny Ka-Ho; Mak, Lung-Yi; Cheung, Tan-To; Zhang, Sai-Sai; Chau, Hau-Tak; Hui, Rex Wan-Hin; Seto, Wai-Kay; Yuen, Man-Fung

Identification of FAT4 as a positive prognostic biomarker in DLBCL by comprehensive genomic analysis

通过全面的基因组分析鉴定出FAT4是弥漫性大B细胞淋巴瘤(DLBCL)的阳性预后生物标志物。

Lv, Liyang; Qi, Xiaolong; Wang, Chun; Ma, Yutong; Nie, Yuling; Abulaiti, Renaguli; Zhang, Fang; Shi, Qiping; Kou, Zhen; Abuduer, Muhebaier; Zhai, Shunsheng; An, Li; Huang, Qin; Gu, Zailinuer; Ou, Qiuxiang; Liu, Hong; Wang, Zengsheng; Shao, Yang; Sun, Zhenzhu; Fu, Ling; Wang, Xiaomin; Mao, Min; Li, Yan

Expression of Concern: MiR-106b-5p Regulates the Migration and Invasion of Colorectal Cancer Cells by Targeting FAT4

关注事项:miR-106b-5p 通过靶向 FAT4 调控结直肠癌细胞的迁移和侵袭

Atypical cadherin FAT4 orchestrates lymphatic endothelial cell polarity in response to flow

非典型钙黏蛋白FAT4在流动条件下调控淋巴管内皮细胞极性。

Kelly L Betterman ,Drew L Sutton ,Genevieve A Secker ,Jan Kazenwadel ,Anna Oszmiana ,Lillian Lim ,Naoyuki Miura ,Lydia Sorokin ,Benjamin M Hogan ,Mark L Kahn ,Helen McNeill ,Natasha L Harvey